Sinemet: Clinical Trials

5 trials of Sinemet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Terminated 2, Withdrawn 1

Follow Sinemet: new trials by email Literature Review of Sinemet trials Research Report on Sinemet

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
Carbidopa/levodopa, Placebo, Exercise training - Depressive Disorder
Phase 4TerminatedNew York State Psychiatric Institute12021-10-072023-02-02
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
Carbidopa/levodopa, Placebo - Depression, Cognitive Impairment
Phase 4TerminatedNew York State Psychiatric Institute52021-02-102023-05-22
Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
Levodopa+carbidopa, Placebo - Depression
Phase 4CompletedEmory University572015-10-092022-09-19
Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
Placebo, Levodopa / Carbidopa, Armeo - Stroke
Phase 4WithdrawnRoss D. Zafonte, MD2015-03-012021-12-27
Effect of L-dopa In Subacute Back Pain Population
Naproxen, Carbidopa/Levodopa, Placebo - Sub-acute Back Pain
Phase 4CompletedNorthwestern University722015-02-242021-03-24

Conditions studied

Depression (2)  ·  Anhedonia (1)  ·  Cognitive Dysfunction (1)  ·  Depressive Disorder (1)  ·  Inflammation (1)  ·  Pain (1)  ·  Psychomotor Disorders (1)  ·  Stroke (1)

Sponsors

New York State Psychiatric Institute (2)  ·  Emory University (1)  ·  Northwestern University (1)  ·  Ross D. Zafonte, MD (1)

Countries

United States (5)

Top investigators

Bret R Rutherford, MD (2)  ·  Apkar Apkarian, PhD (1)  ·  Duc A Tran, MD PhD (1)  ·  Jennifer Felger, PhD (1)  ·  Paolo Bonato, PhD (1)  ·  Ross Zafonte, DO (1)  ·  Thomas J Schnitzer (1)

Results publications

PMID 34374961, PMID 35927580

NIH funding

K24MH122514 (1), R01DE022746 (1), R01MH109637 (1), R01MH123660 (1)